YGEN.L Regulatory News (YGEN)

24 Sep 2007 08:00

ViaLogy PLC24 September 2007 24th September 2007Embargoed until: 0800hrs ViaLogy appoints Dr. Robert Dean as CEO ViaLogy PLC (VIY), the AIM-quoted technology company that is the leadinginnovator of network-centric, real time signal processing platforms for sensorapplications, today announces the appointment of Dr. Robert W Dean as Presidentand Chief Executive Officer (CEO) of ViaLogy LLC, its wholly-owned Americansubsidiary company based in Pasadena, California. Dr. Dean, who has served as anon-executive director on the ViaLogy PLC board since it joined AIM last year,will become an executive director on the main board. Dr. Dean moves to ViaLogy from the Science Applications InternationalCorporation (SAIC), a global systems and technical services company where he wasSenior Vice President, Corporate Market Development. Previously he has heldsenior management and board positions, concentrating on business development andstrategic planning, with such international organisations as Boeing, LockheedMartin, United Space Alliance, MacDonald Dettwiler, Electro Optic Systems, theRand Corporation and the Ball Corporation. During the President Reagan's term Dr. Dean served as Special Assistant to thePresident and was Senior Director of the National Security Council. He was alsothe senior White House executive responsible for high technology issues. Duringhis distinguished career he has held senior positions with the CentralIntelligence Agency and the US Department of State. He has received numerousawards for public service including the Grand Service Cross of the FederalRepublic of Germany, which is the highest civilian honour awarded to a foreigncitizen. "We are delighted that Bob Dean has agreed to accept the most senior managementposition with ViaLogy," said executive chairman, Terry Bond. "He has theexperience and vision that makes him the ideal person to lead us at thisexciting time in the company's development. Our technology has now beenvalidated for a number of important industrial applications. Next month,October, we will be announcing and demonstrating ViaLogy's commercial productsfor defence, oil and gas and enterprise management and business continuityapplications." Said Dr. Dean: "During the time I have served as a non-executive director ofViaLogy I have been very impressed by the potential of the company's technologyand products and the abilities of its staff. I look forward to growing the salesand marketing organisation and deploying ViaLogy products for partners andcustomers in the US and globally. "I am confident that ViaLogy will achieve the success in the market place thatits unique technology deserves." End For further information please contact: ViaLogyTerry Bond, Chairman +44 (0)1235 834734 or 07860 842756 Seymour Pierce (Broker)Mark Percy, Nominated Adviser +44 (0)20 7107 8032 Redleaf CommunicationsEmma Kane / Samantha Robbins +44 (0)20 7822 0200 About ViaLogy: Network Centric Signal Processing. ViaLogy is a leading innovator of network-centric, real-time signal processingplatforms for sensor applications. ViaLogy is currently deploying and designingcomputational systems, powered by its patented technologies, for applications inlife sciences, public safety and security, surveillance, defence andgeoseismology. Vialogy focuses on market driven problems where automation,timeliness, quality and reliability of information processing are essential.ViaLogy's core competency incorporates rapidly and accurately detecting weaksignals buried in high noise background and clutter. This technology can beemployed to solve problems involving sensor integration and information overloadchallenges involving video, telephony and control sensors, as well as forenhancement of numerous signal processing applications. For more information,visit our website at www.vialogy.com. Except for statements of historical fact, the information presented hereinconstitutes forward-looking statements within the meaning of the PrivateSecurities Litigation Reform Act of 1995. Such forward-looking statementsinvolve known and unknown risks, uncertainties and other factors which may causethe actual results, performance or achievements of the company to be materiallydifferent from any future results, performance or achievements expressed orimplied. This information is provided by RNS The company news service from the London Stock Exchange